Product Code: SR112023A3929
Abstract
The global medical plastics market size reached US$ 25.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2022-2028.
Medical plastics refer to various polymeric materials manufactured specifically for healthcare applications. They are commonly used for tamper-proof caps, vials, beakers, inhalations masks, bedpans, intravenous (IV) tubes, pill casings, surgical instruments, prosthetics and catheters. Some of the commonly used variants include silicon, synthetic rubber, polymer blends, high performance and engineering plastics. They are produced using hypoallergenic, biocompatible, medical-grade polypropylene and polycarbonate materials. They are shatter-proof, non-permeable, temperature, chemical and corrosion-resistant and can have frequent sterilization cycles. Medical plastics can also be used to transport biohazardous materials as they have antimicrobial surfaces and can aid in preventing the spread of pathogens.
Global Medical Plastics Market Trends:
Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for single-use medical plastics and consumables in the healthcare centers. Hospitals, diagnostic centers and clinics are extensively using thermal scanners, ventilators, gloves, respirators and masks for the treatment of the patients. Additionally, various product innovations, such as the development of medical plastics with enhanced biocompatibility, are acting as other growth-inducing factors. These novel variants are more cost-effective and are used in targeted drug delivery systems for the controlled release of drugs in complex parts of the brain and to treat various degenerative diseases. Other factors, including extensive improvements in the healthcare infrastructure, especially in the developing economies, along with the rising geriatric population, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical plastics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on material and application.
Breakup by Material:
Polyvinyl Chloride (PVC)
Polypropylene (PP)
Engineering Plastics
Polyethylene (PE)
Polystyrene (PS)
Silicones
Others
Breakup by Application:
Disposables
Drug Delivery Devices
Diagnostic Instruments
Catheters
Surgical Instruments
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.) and Trinseo PLC.
Key Questions Answered in This Report
- 1. What was the size of the global medical plastics market in 2022?
- 2. What is the expected growth rate of the global medical plastics market during 2023-2028?
- 3. What has been the impact of COVID-19 on the global medical plastics market?
- 4. What are the key factors driving the global medical plastics market?
- 5. What is the breakup of the global medical plastics market based on the material?
- 6. What is the breakup of the global medical plastics market based on the application?
- 7. What are the key regions in the global medical plastics market?
- 8. Who are the key players/companies in the global medical plastics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Medical Plastics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Material
- 6.1 Polyvinyl Chloride (PVC)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Polypropylene (PP)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Engineering Plastics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Polyethylene (PE)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Polystyrene (PS)
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Silicones
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Application
- 7.1 Disposables
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Drug Delivery Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Diagnostic Instruments
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Catheters
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Surgical Instruments
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Arkema SA
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 BASF SE
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Celanese Corporation
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Covestro AG
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.5 The Dow Chemical Company
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 DuPont de Nemours Inc
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Evonik Industries AG
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Exxon Mobil Corporation
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.9 SABIC
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Solvay S.A.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 The Lubrizol Corporation (Berkshire Hathaway Inc.)
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 SWOT Analysis
- 13.3.12 Trinseo PLC
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.12.3 Financials